Psychological and Neurocognitive Dimensions of Kidney Disease: Mental Health Impacts of Chronic Hypertension and Systemic Illness

Authors

DOI:

https://doi.org/10.65327/kidneys.v15i1.614

Keywords:

Chronic kidney disease, albuminuria, cognition, depression, hypertension

Abstract

Background:
Hypertension and chronic kidney disease are now considered systemic disorders associated with vascular, metabolic, and inflammatory dysfunction, which may also cause depressive symptoms and cognitive impairment in the elderly. In this study, the researchers assessed how kidney disease indicators, hypertension status, depressive symptoms and neurocognitive performance were related in a nationally representative ageing population.

Methods:
Secondary analysis was performed based on the 2013-2014 National Health and Nutrition Examination Survey. The key inclusion criteria were participants aged 60 to 80 years and full data on blood pressure, estimated glomerular filtration rate, urine albumin-to-creatinine ratio, and depressive symptoms measured by the Patient Health Questionnaire-9 and standardized cognitive tests. Associations between kidney markers, hypertension status, depressive symptoms and cognitive outcomes were investigated using multivariable linear regression models after adjusting for age and sex.

Results:
The poorer cognitive performance was linked to higher albuminuria, especially in the processing speed and executive ability. Estimated glomerular filtration rate was not independently associated with cognitive outcomes after adjustment. Greater depressive symptom burden was consistently associated with lower cognitive scores across all domains. Both lower estimated glomerular filtration rate and higher albuminuria were associated with increased depressive symptoms. Hypertension status demonstrated domain-specific associations with cognitive performance.

Conclusions:
Albuminuria and depressive symptoms are independently associated with neurocognitive performance in older adults, highlighting the importance of integrated renal, mental health, and cognitive screening strategies in aging populations.

 

Downloads

Download data is not yet available.

Author Biographies

Lalit Kumar Singh

Associate Professor, Department of Psychiatry, PGIMER, Chandigarh Specialzation: Cognitive Behaviour Therapy, Spiritual Psychotherapy, Vedantic Philosophy, ORCID ID: https://orcid.org/0000-0002-7145-5155 llt_kumar@yahoo.com

Dr. Kiran Srivastava

Associate Professor, Department of Psychology, University Institute of Liberal Arts and Humanities (UILAH), Chandigarh University, Mohali-Punjab,Specialization: Neuropsychology, Cognitive Behaviour Therapy, Rorschach Test, Dementia
ORCID ID:
https://orcid.org/0000-0002-4312-1641 kiran_srivastava63@yahoo.com

Tosendra Dwivedi

Professor of Psychology, Alliance University, Bangaluru ORCID ID :0000-0002-5766-0363, tosendra.dwivedi@alliance.edu.in

Dr. V.Ashwin Kumar

Assistant Professor Department of Anaesthesiology Vinayaka Missions Medical College, Karaikal (Vinayaka Missions Research Foundation), ORCID ID: 0009-00023009-9374 dr.ashwinkumar18@gmail.com

Mr Sandeep Ameta

Senior Nursing Officer, Department of Psychiatry Guru Teg Bahadur Hospital Govt of NCT Delhi, ORCID ID: 0009-0002-1580-4557 ametasandeep.clinicalpsych@gmail.com

References

Tang C, Livingston MJ, Safirstein R, Dong Z. Cisplatin nephrotoxicity: new insights and therapeutic implications. Nature Reviews Nephrology . 2023 Jan;19(1):53-72.

Fang CY, Lou DY, Zhou LQ, Wang JC, Yang B, He QJ, Wang JJ, Weng QJ. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacologica Sinica. 2021 Dec;42 (12) :1951-69.

Rahman MA, Akter S, Dorotea D, Mazumder A, Uddin MN, Hannan MA, Hossen MJ, Ahmed MS, Kim W, Kim B, Uddin MJ. Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction. Frontiers in Pharmacology. 2022 Jul 15;13:925993.

Li Q, Xing C, Yuan Y. Mitochondrial targeting of herbal medicine in chronic kidney disease. Frontiers in pharmacology. 2021 May 26;12:632388.

Feng J, Chen Z, Liang W, Wei Z, Ding G. Roles of mitochondrial DNA damage in kidney diseases: a new biomarker. International Journal of Molecular Sciences. 2022 Dec 2;23(23):15166.

Paes AS, Koga RD, Sales PF, Santos Almeida HK, Teixeira TA, Carvalho JC. Phytocompounds from Amazonian Plant Species against Acute Kidney Injury: Potential Nephroprotective Effects. Molecules . 2023 Sep 2;28(17):6411.

Chen L, Deng Y, Hu J, Gong X. Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury. Frontiers in Pharmacology. 2025 Feb 19;16:1539886.

Han C, Gao RR, Zhou L, Li W. The gut–kidney axis is regulated by astragaloside IV to inhibit cyclosporine A-induced nephrotoxicity. Frontiers in Pharmacology. 2025 Jan 27;16:1518481.

Weir MA, Walsh M, Cuerden MS, Sontrop JM, Urquhart BL, Lim YJ, Chambers LC, Garg AX. The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial. Nephrology Dialysis Transplantation. 2023 Oct;38(10):2192-200.

Sattarinezhad A, Roozbeh J, Yeganeh BS, Omrani GR, Shams M. Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial. Diabetes & Metabolism. 2019 Jan 1;45(1):53-9.

Chen YQ, Chen HY, Tang QQ, Li YF, Liu XS, Lu FH, Gu YY. Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines. Frontiers in pharmacology. 2022 Sep 2;13:968226.

Rong Q, Han B, Li Y, Yin H, Li J, Hou Y. Berberine reduces lipid accumulation by promoting fatty acid oxidation in renal tubular epithelial cells of the diabetic kidney. Frontiers in pharmacology. 2022 Jan 5;12:729384.

Kim JY, Jo J, Leem J, Park KK. Inhibition of p300 by garcinol protects against cisplatin-induced acute kidney injury through suppression of oxidative stress, inflammation, and tubular cell death in mice. Antioxidants. 2020 Dec 14;9(12):1271.

Silveira MA, Teles F, Berretta AA, Sanches TR, Rodrigues CE, Seguro AC, Andrade L. Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial. BMC nephrology. 2019 Apr 25;20(1):140.

Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey (NHANES): Questionnaires, datasets, and documentation [Internet]. Atlanta (GA): CDC; c2024 [cited 2026 Jan 21]. Available from: https://wwwn.cdc.gov/nchs/nhanes/Default.aspx

Hu HC, Lei YH, Zhang WH, Luo XQ. Antioxidant and anti-inflammatory properties of resveratrol in diabetic nephropathy: a systematic review and meta-analysis of animal studies. Frontiers in Pharmacology. 2022 Mar 9;13:841818.

Josa E, Barril G, Ruperto M. Potential Effects of Bioactive Compounds of Plant-Based Foods and Medicinal Plants in Chronic Kidney Disease and Dialysis: A Systematic Review. Nutrients. 2024 Dec 14;16(24):4321.

Macena MD, Nunes LF, da Silva AF, Pureza IR, Praxedes DR, Santos JC, Bueno NB. Effects of dietary polyphenols in the glycemic, renal, inflammatory, and oxidative stress biomarkers in diabetic nephropathy: a systematic review with meta-analysis of randomized controlled trials. Nutrition reviews. 2022 Dec 1;80(12):2237-59.

Zhang X, He H, Liang D, Jiang Y, Liang W, Chi ZH, Ma J. Protective effects of berberine on renal injury in streptozotocin (STZ)-induced diabetic mice. International journal of molecular sciences. 2016 Aug 12;17(8):1327.

Opazo-Ríos L, Mas S, Marín-Royo G, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. International journal of molecular sciences. 2020 Apr 10;21(7):2632.

Zeni L, Norden AG, Cancarini G, Unwin RJ. A more tubulocentric view of diabetic kidney disease. Journal of nephrology. 2017 Dec;30(6):701-17.

Qin X, Jiang M, Zhao Y, Gong J, Su H, Yuan F, Fang K, Yuan X, Yu X, Dong H, Lu F. Berberine protects against diabetic kidney disease via promoting PGC‐1α‐regulated mitochondrial energy homeostasis. British Journal of Pharmacology. 2020 Aug;177 (16):3646-61.

Ma X, Chen Z, Wang L, Wang G, Wang Z, Dong X, Wen B, Zhang Z. The pathogenesis of diabetes mellitus by oxidative stress and inflammation: its inhibition by berberine. Frontiers in Pharmacology. 2018 Jul 27;9:782.

Park HS, Lim JH, Kim MY, Kim Y, Hong YA, Choi SR, Chung S, Kim HW, Choi BS, Kim YS, Chang YS. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy. Journal of translational medicine. 2016 Jun 11;14(1):176.

Li KX, Ji MJ, Sun HJ. An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy. Gene. 2021 May 15;780:145532.

Downloads

Published

2026-01-26

How to Cite

Lalit Kumar Singh, Dr. Kiran Srivastava, Tosendra Dwivedi, Dr. V.Ashwin Kumar, & Mr Sandeep Ameta. (2026). Psychological and Neurocognitive Dimensions of Kidney Disease: Mental Health Impacts of Chronic Hypertension and Systemic Illness. KIDNEYS, 15(1), 167–175. https://doi.org/10.65327/kidneys.v15i1.614

Issue

Section

Research Article